Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review

Overview of attention for article published in Drug Design, Development and Therapy, July 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy: 1 policy source

patent: 1 patent

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Dimensions has found 33 publications that cite this research output.

33

The most recent citing publications are shown below. View all 33 publications that cite this research output on Dimensions.

Long‐term efficacy, safety, and cumulative retention rate of antitumor necrosis factor‐alpha treatment for patients with Behcet's uveitis: A systematic review and meta‐analysis

Article in International Journal of Rheumatic Diseases (February 2024)

Effectiveness and Safety of Weekly Adalimumab for Non-Infectious Chronic Anterior Uveitis in Children

Article in Ocular Immunology and Inflammation (November 2023)

Efficacy, retention rate and safety of adalimumab treatment in patients with non-infectious uveitis and scleritis: a real-world, retrospective, single-centre study

Article in Eye (October 2023)